Casdin Capital, LLC Biolife Solutions Inc Transaction History
Casdin Capital, LLC
- $734 Million
- Q3 2025
A detailed history of Casdin Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Casdin Capital, LLC holds 6,707,165 shares of BLFS stock, worth $161 Million. This represents 23.32% of its overall portfolio holdings.
Number of Shares
6,707,165
Previous 7,707,165
12.97%
Holding current value
$161 Million
Previous $166 Million
3.06%
% of portfolio
23.32%
Previous 23.27%
Shares
15 transactions
Others Institutions Holding BLFS
# of Institutions
206Shares Held
47.6MCall Options Held
12.6KPut Options Held
0-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$97.9 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.6MShares$86.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.97MShares$71.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.46MShares$35.1 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...